Hostname: page-component-7b7567c8c-8tzhz Total loading time: 0 Render date: 2026-11-19T16:03:24.257Z Has data issue: false hasContentIssue false

308 Stakeholder interview feedback to improve remote biomarker capture for decentralized trials

Published online by Cambridge University Press:  08 May 2026

Gaylen Fronk
Affiliation:
Medical University of South Carolina
Margaret Fahey
Affiliation:
Middle Tennessee State University
Amanda Kastrinos
Affiliation:
Medical University of South Carolina
Caitlyn Sebastian
Affiliation:
Medical University of South Carolina
McKay Lucas
Affiliation:
Medical University of South Carolina
John Clark
Affiliation:
Medical University of South Carolina
Jack Kustanowitz
Affiliation:
Mountain Pass Tech
Jennifer Dahne
Affiliation:
Medical University of South Carolina
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Objectives/Goals: We previously developed and evaluated a system called MyTrials, which captures biomarker data remotely. We sought to improve that platform to support additional methods of remote biomarker capture, which is especially important in research such as substance use and co-use studies where participants provide several biological verifications. Methods/Study Population: To determine how best to adapt MyTrials, we conducted qualitative interviews with key stakeholders. Our sample of end users (i.e., participants, N=10) included 6 women (3 men and 1 nonbinary participant), 6 White participants (2 Black participants, 1 Asian participant, and 1 multiracial participant), 6 participants with education beyond high school (4 participants with high school/GED), with a mean age of 36.33 years (age range: 21–75), and with a range of substance use behavior (combustible cigarettes [N=6], e-cigarettes [N=3], cannabis use [N=5], and no substance use [N=2]). Our sample of potential customers (N=22) included 12 research investigators, 2 biospecimen lab representatives, 3 research coordinators, 3 representatives from large NIH grant initiatives (ABCT, CTN, and CTSA), and 2 REDCap engineers/managers. Results/Anticipated Results: Emerging themes included 1) suggestions for technical requirements including reliability of core functions, app usability, support access, and data security/compliance and 2) suggestions for commercialization including clarity of instructions, operational logistics, trust in the data collection process, IRB/funder acceptance, and participant retention enablers. Discussion/Significance of Impact: Key feedback themes will inform product improvement to meet the needs for decentralized clinical trials to collect biological or health data without in-person participation.

Information

Type
Inclusive Health and Community Engagement
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2026. The Association for Clinical and Translational Science